Home LiteratureArticle Details
PMID: 11873779 Published · ppublish English Letter Comment

Angiotensin-receptor blockers, type 2 diabetes, and renoprotection.

The New England journal of medicine ·Vol. 346 ·No. 9 ·2002-02-28 ·Pages 705-7

Ceriello A, Motz E

Abstract

暂无摘要

MeSH Terms
Angiotensin Receptor Antagonists Antihypertensive Agents/pharmacology,therapeutic use Biphenyl Compounds/pharmacology,therapeutic use Diabetes Mellitus, Type 2/complications Diabetic Nephropathies/drug therapy,metabolism Humans Irbesartan Losartan/pharmacology,therapeutic use Oxidative Stress/drug effects Tetrazoles/pharmacology,therapeutic use
Chemicals
Angiotensin Receptor Antagonists Antihypertensive Agents Biphenyl Compounds Tetrazoles Irbesartan Losartan
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Ceriello Antonio
Motz Enrico
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
Published
2002-02-28
Pages
705-7
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
PMID: 11565517
CommentOn
PMID: 11565518
CommentOn
PMID: 11565519
External Links
PubMed source View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2